Literature DB >> 18628753

The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders.

Seithikurippu R Pandi-Perumal1, Ilya Trakht, D Warren Spence, Venkataramanujan Srinivasan, Yaron Dagan, Daniel P Cardinali.   

Abstract

Normal circadian rhythms are synchronized to a regular 24 h environmental light-dark cycle, and the suprachiasmatic nucleus and the hormone melatonin have important roles in this process. Desynchronization of circadian rhythms, as occurs in chronobiological disorders, can produce severe disturbances in sleep patterns. According to the International Classification of Sleep Disorders, circadian rhythm sleep disorders (CRSDs) include delayed sleep phase syndrome, advanced sleep phase syndrome, non-24 h sleep-wake disorder, jet lag and shift-work sleep disorder. Disturbances in the circadian phase position of plasma melatonin levels have been documented in all of these disorders. There is compelling evidence to implicate endogenous melatonin as an important mediator in CRSD pathophysiology, although further research involving large numbers of patients will be required to clarify whether the disruption of melatonin secretion is a causal factor in CRSDs. In this Review, we focus on the use of exogenous melatonin and light therapy to treat the disturbed sleep-wake rhythms seen in CRSDs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628753     DOI: 10.1038/ncpneuro0847

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  26 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Modeling Reveals a Key Mechanism for Light-Dependent Phase Shifts of Neurospora Circadian Rhythms.

Authors:  Jacob Bellman; Jae Kyoung Kim; Sookkyung Lim; Christian I Hong
Journal:  Biophys J       Date:  2018-08-04       Impact factor: 4.033

4.  Effects of bright light exposure during daytime on peripheral clock gene expression in humans.

Authors:  Maki Sato; Tomoko Wakamura; Takeshi Morita; Akihiko Okamoto; Makoto Akashi; Takuya Matsui; Motohiko Sato
Journal:  Int J Biometeorol       Date:  2016-12-17       Impact factor: 3.787

5.  Therapeutic benefit of melatonin in refractory central serous chorioretinopathy.

Authors:  A L Gramajo; G E Marquez; V E Torres; C P Juárez; R E Rosenstein; J D Luna
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

6.  Pharmacological modulators of the circadian clock as potential therapeutic drugs.

Authors:  Marina P Antoch; Mikhail V Chernov
Journal:  Mutat Res       Date:  2009-08-14       Impact factor: 2.433

7.  Estimation methods for human circadian phase by use of peripheral tissues.

Authors:  Ritsuko Matsumura; Koichi Node; Makoto Akashi
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

Review 8.  Genetics of Circadian Rhythms.

Authors:  Tomas S Andreani; Taichi Q Itoh; Evrim Yildirim; Dae-Sung Hwangbo; Ravi Allada
Journal:  Sleep Med Clin       Date:  2015-12

9.  Therapeutic applications of melatonin.

Authors:  Ifigenia Kostoglou-Athanassiou
Journal:  Ther Adv Endocrinol Metab       Date:  2013-02       Impact factor: 3.565

Review 10.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.